Skip to main content
. Author manuscript; available in PMC: 2021 Mar 10.
Published in final edited form as: J Am Coll Cardiol. 2020 Feb 4;75(4):395–405. doi: 10.1016/j.jacc.2019.11.039

TABLE 1.

Ventricular and Regurgitant Volumes (MRI) at Baseline and 90 Days

AR
AR+MI
p Intergroups
Baseline Follow-Up Baseline Follow-Up Baseline Follow-Up
LVEDV, ml 87 ± 7 186 ± 54 84 ± 5 178 ± 53 0.555 0.809
LVESV, ml 39 ± 2 110 ± 44 36 ± 8 101 ± 43 0.414 0.692
LVEF, % 55 ± 3 42 ± 7 57 ± 10 45 ± 9 0.700 0.559
RVEDV, ml 72 ± 15 88 ± 10 71 ± 3 82 ± 7 0.742 0.290
RVESV, ml 23 ± 9 32 ± 10 25 ± 8 28 ± 7 0.347 0.434
RVEF, % 69 ± 6 63 ± 10 65 ± 12 65 ± 9 0.132 0.710
MR fraction, % 4 ± 5 4 ± 7 1 ± 2 19 ± 10 0.419 0.019
AR fraction, % 27 ± 8 26 ± 10 0.812

Values are mean ± SD.

AR = aortic regurgitation; CMR = cardiac magnetic resonance; LVEDV = left ventricular end-diastolic volume; LVEF = left ventricular ejection fraction; LVESV = left ventricular end-systolic volume; MI = myocardial infarction; MR = mitral regurgitation; MRI = magnetic resonance imaging; MV = mitral valve; RVEDV = right ventricular end-diastolic volume; RVEF = right ventricular ejection fraction; RVESV = right ventricular end-systolic volume.